Skip to content

BIO-SANTE

Active
Private limited companyfounded 200818 yrs activeDe Wandstraat 150, 1020 Brussel, BelgiumKBO/BCE: BE 0898.125.572

BIO-SANTE has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €144k and a net result of €11k. Equity is growing by ~13.3% per year across the filed fiscal years. Its solvency ranks better than 81% of 3121 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Checked score

Score 2025
80 / 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability76▲+1
Solvency96▼-4
Growth78=
Track record100
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €11k at 30 days acceptable
Liquidity ample (current ratio 2.46 against 3.3 in 2024; short-term debt: 28.8% and cash: 8.8% of total assets), and 28.8% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Seven signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 01
Relative position
BE, all sectors
reference
Sector 01
lower
← fewer bankruptcies more bankruptcies →
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 18 years 0 20 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
71.2%
Return on assets
5.5%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
31 d late
2024
82 d late
2023
89 d late
2022
72 d late
2021
117 d late
2020
89 d late
2019
117 d late
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
23-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€144k▼ 32.4%
2024 · €213k
2018: €55k 2019: €61k 2020: €74k 2021: €157k 2022: €177k 2023: €198k 2024: €213k
2018 → 2025
Total assets
€202k▼ 26.3%
2024 · €274k
2018: €193k 2019: €191k 2020: €200k 2021: €304k 2022: €290k 2023: €313k 2024: €274k
2018 → 2025
Net result
€11k▼ 23.3%
2024 · €15k
2018: €1k 2019: €6k 2020: €13k 2021: €83k 2022: €20k 2023: €21k 2024: €15k
2018 → 2025
Working capital
€85k▼ 39.9%
2024 · €141k
2018: €6k 2019: €36k 2020: €27k 2021: €164k 2022: €185k 2023: €193k 2024: €141k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€157k-€177k▲ 12.4%€198k▲ 12.0%€213k▲ 7.3%€144k▼ 32.4%
Operating result€129k-€31k▼ 75.7%€36k▲ 16.3%€28k▼ 21.5%€23k▼ 19.8%
Net result€83k-€20k▼ 76.5%€21k▲ 8.1%€15k▼ 31.5%€11k▼ 23.3%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€50k€100k€150kOperating result 2021: €129k€129kNet result 2021: €83k€83kOperating result 2022: €31k€31kNet result 2022: €20k€20kOperating result 2023: €36k€36kNet result 2023: €21k€21kOperating result 2024: €28k€28kNet result 2024: €15k€15kOperating result 2025: €23k€23kNet result 2025: €11k€11k20212022202320242025
The operating result has fallen two years in a row; 2025 is 20% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €202k
Fixed assets €59k▼ 17.5%
Current assets €143k▼ 29.4%
Equity and liabilities €202k
Equity €144k▼ 32.4%
Debt €58k▼ 5.1%
The debt ratio rises from 22.4% to 28.8%. Equity and debt are lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€36k
2024 · €44k
Cash flow
€24k
2024 · €30k
Solvency
71.2%
2024 · 77.6%
Current ratio
2.46
2024 · 3.30
Quick ratio
0.75
2024 · 1.56
Debt / equity
0.40
2024 · 0.29
ROE
7.7%
2024 · 6.8%
ROA
5.5%
2024 · 5.3%
Interest coverage
9.57
2024 · 8.99
Debt
€58k
2024 · €61k
Debt ≤ 1 year
€58k
2024 · €61k
Income taxes
€9k
2024 · €11k
Staff costs
€48k
2024 · €55k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€274k€202k
Fixed assets21/28€72k€59k
Tangible fixed assets22/27€72k€59k
Land and buildings22€53k€46k
Furniture and vehicles24€19k€13k
Current assets29/58€202k€143k
Amounts receivable after more than one year29€81k€9k
Other amounts receivable291€81k€9k
Stocks and contracts in progress3€107k€99k
Stocks30/36€107k€99k
Amounts receivable within one year40/41€6k€15k
Trade receivables40€1k€14k
Other amounts receivable41€4k€779
Cash at bank and in hand54/58€6k€18k
Deferred charges and accrued income490/1€3k€2k
Equity and liabilities
Total equity and liabilities10/49€274k€202k
Equity10/15€213k€144k
Contributions10/11€19k€19k=
Reserves13€194k€125k
Distributable reserves133€194k€125k
Amounts payable17/49€61k€58k
Amounts payable within one year42/48€61k€58k
Current portion of amounts payable after more than one year42€1k€1k
Financial debts43€124€124=
Credit institutions430/8€124€124=
Trade debts44€48k€38k
Suppliers440/4€48k€38k
Taxes, remuneration and social security45€12k€19k
Taxes450/3€3k€8k
Remuneration and social security454/9€9k€11k
Income statement Code20242025
Remuneration, social security and pensions62€55k€48k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€16k€13k
Other operating charges640/8€2k€1k
Gross operating margin9900€101k€86k
Operating profit (loss)9901€28k€23k
Financial income75/76B€2k€630
Recurring financial income75€2k€630
Financial charges65/66B€5k€4k
Recurring financial charges65€5k€4k
Profit (loss) for the period before taxes9903€25k€20k
Income taxes67/77€11k€9k
Profit (loss) for the period9904€15k€11k
Profit (loss) for the period to be appropriated9905€15k€11k
Appropriation of the result
Profit (loss) to be appropriated9906€15k€11k
Transfer from equity791/2-€80k
Transfer to equity691/2€15k€11k
To other reserves6921€15k€11k
Profit to be distributed694/7-€80k
Return on contributions (dividend)694-€80k

The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
31-08
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 31 days late
2025
21-10
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 82 days late
2024
31-12
Financial Equity above €200kEq €213k ▲7.3%
7 profitable years in a row build equity to €213k.
28-10
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 89 days late
2023
11-10
NBB filing Annual accounts filed
fiscal year 2022 · micro schema · 72 days late
2022
25-11
NBB filing Annual accounts filed
fiscal year 2021 · micro schema · 117 days late
2021
31-12
Financial Highest result since 2018net €83k ▲566%
Operating result €129k, net result €83k, both a record.
31-12
Financial Equity above €150kEq €157k ▲113%
4 profitable years in a row build equity to €157k.
28-10
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema · 89 days late
2020
25-11
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema · 117 days late
2019
31-08
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema · 31 days late
2018
27-09
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema · 58 days late
2017
26-09
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema · 57 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Brussel · 1 establishment unit since 2008
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

De Wandstraat 1501020 Brussel
Ground area
194 m²
Building footprint
101 m²
Volume, LiDAR
873 m³
Parcel 21818A0247/00H008, Brussels · tallest building 14.5 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
BIO - SANTE
De Wandstraat 150, 1020 BrusselWholesale trade
since 20082.172.048.348
1 parcel
Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21818A0247/00H008 Brussels 194 m² 1 · 101 m² 14.5 m · 3 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Recognitions · licences · registrations

Food safety, FASFC

1 site
Brussel2.172.048.348
1 permission
Toelating · Detailhandel · since 01-09-2008

Similar companies · same sector, comparable size

Of 93 companies in sector 01280 we hold annual accounts for 19. 12 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded26-05-2008
Fiscal year end31-12
Activities, NACEBEL
01280Crop and animal production, hunting and related service activities
47740Retail trade
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
Sources
Crossroads Bank for EnterprisesNational Bank · 17 filingsAddress and cadastre registers

Data from official sources, last processed on 23-09-2026. Scores and ratios are computed by Checked and are not a credit decision.

Contact details

3 entries
Enterprise
E-mail:biosantewand@gmail.com
Enterprise
Phone:0479/31.43.95
Establishment Brussel 2.172.048.348